Emaretamig
Based on 1 Customer Validation
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor targeting CLDN18 and CD3E. Abdakibart can be used for cancers like gastric and pancreatic cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 97.96%
- CAS No.: 3051701-97-1
- Masse moléculaire:175.038 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
immunoglobulin (H-gamma1_L-kappa)_(G1(VH-CH1-h)-10merscFvlh-10mer-G1(h-CH2-CH3)_L-kappa)
Human
|
Claudin-18 |
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
half-G1-kappa_VH-CH1-h-(scFv-lambda-heavy)-h-CH2-CH3
ELISA, FACS, Functional assay
-
Immobilized Claudin-18 Protein, Human (HEK293, HY-P78368) can bind Emaretamig, The ED50 for this effect is 83.60 ng/mL. -
Immobilized CD3 epsilon Protein, Human (HEK293, HY-P70506) can bind Emaretamig. The ED50 for this effect is 190.9 ng/mL.
Chemical Information
-
CAS No. 3051701-97-1
-
Appearance Liquid
-
Masse moléculaire 175.038 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
Synonyms
ASP-2138
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)